-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With the approach of the fifth batch of national procurement bids, more and more companies have obtained tickets for the national procurement bidding
1.
1.
According to the Insight database, Shanghai Shangyao Xinya's Lansoprazole for injection is the 5th company that has been evaluated
Hainan Beite’s azithromycin injection passed the consistency evaluation on March 22, and this time it is the new specification
Hanyu Pharmaceutical's Thymus Law is the fifth company to pass the consistency evaluation, and two other companies are in the process of applying for supplementary consistency evaluation
Hubei Keyi Pharmaceutical's ganciclovir is the fourth company to evaluate this variety, and one company has already submitted a supplementary application
Public information shows that the sales of lansoprazole in 2019 have exceeded 2 billion yuan, and the new sales of thymus for terminal injection in public medical institutions in China in 2018 were 2.
2 , injections into the protagonist
2 , injections into the protagonistIt can be seen from the previous 4 collections that most of them are oral dosage forms
As we all know, injections have always been a hot spot in the industry
Compared with before, the rules of injection dosage form have changed a little
In fact, it is not only national procurement, but also from the procurement policies of various provinces and inter-provincial alliances that injections have become a popular product
As early as May last year, the consistency evaluation of injections had begun
3 , leading Pharmaceutical gathered, started a price war
3 , leading Pharmaceutical gathered, started a price warAccording to GBI data, as of June 8th, in terms of the number of drugs, China Biopharmaceuticals had the most reviewed drugs, with 13 drugs selected.
In terms of generic drug companies, the fifth batch of 58 nationally sourced products will usher in the competition of 122 over-evaluated companies
It can be seen from the fifth batch of collections of Hengrui Medicine that 8 varieties have entered, including oxaliplatin injection, cisatracurium benzenesulfonate injection, iodixanol injection, dutaxis Amine soft capsule, docetaxel injection, glycopyrrolate injection, ropivacaine hydrochloride injection and palonosetron hydrochloride injection